Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.
665 result(s)
06/04/2020
08:37
286.02 KB

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

 

06/04/2020
08:35
38.17 KB

TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR UN EMETTEUR SUR SES PROPRES TITRES

30/03/2020
13:56
295.15 KB

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

26/03/2020
15:25
bytes
Présentation analystes & investisseurs - 26 mars 2020
26/03/2020
08:00
2.02 MB
26/03/2020
08:00
855.06 KB
At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon.
23/03/2020
16:14
296.32 KB

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

20/03/2020
13:26
188.47 KB

Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions.

04/03/2020
09:57
288.99 KB

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

 

04/03/2020
09:54
38.07 KB

TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR UN EMETTEUR SUR SES PROPRES TITRES

12/02/2020
22:30
1016.32 KB

February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health. This acquisition will be financed through a combination of available cash and committed financing from Vetoquinol banking partners for $140 million in an all cash deal subject to customary post-closing adjustments. The deal is expected to close by mid-year 2020.

07/02/2020
10:11
38.31 KB

TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR UN EMETTEUR SUR SES PROPRES TITRES

07/02/2020
10:09
285.83 KB

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

 

23/01/2020
18:00
788.83 KB

The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates.

 

 

 

06/01/2020
15:18
284.99 KB

Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 31 décembre 2019

 
06/01/2020
15:14
285.65 KB

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

 

06/01/2020
15:12
73.48 KB

TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR UN EMETTEUR SUR SES PROPRES TITRES

16/12/2019
18:00
704.76 KB

December 16, 2019 (Lure, France) - Vetoquinol published its calendar of financial communication for 2020.

13/12/2019
08:30
240.56 KB

December 12, 2019 (Lure, France) - Vetoquinol S.A. and Klox Technologies Limited, a subsidiary of Klox Technologies Inc., have entered into an exclusive global licensing agreement, excluding the People’s Republic of China. Through this agreement, Vetoquinol will develop and commercialize Klox’s fluorescent light energy (FLE) products in animal health.

 

 

 

05/12/2019
09:34
37.89 KB

TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR UN EMETTEUR SUR SES PROPRES TITRES

Basket
Empty basket

INVESTORS CORNER

Vetoquinol has been listed on the Euronext Paris stock market since November 16th.

Consult the documents of the Meeting

Contact

Composition of the bodies of Corporate Management and Governance

Financial information and key figures: annual, half-year and by sector key figures